Table 8. The effect of CDSS on medication monitoring .
References | CDSS focus (study objective) | Effect measures | Main findings |
(25) | Evaluating the effects of CCDSS effects on therapeutic drug monitoring and dosing (TDMD) in randomized controlled trials (RCTs) | Improved therapeutic drug monitoring and dosing (TDMD) | CDSS can improve TDMD, particularly in the dosing of insulin and vitamin K; however, it needs to be further developed |
(101) | Identifying studies that have investigated the HIT interventions to enhance laboratory observing of chosen high-risk drugs in the ambulatory situation. | The was not enough evidence to demonstrate the HIT impact in enhancing laboratory observing of particular high-risk drugs for ambulatory patients | Overall, practically half of the randomized controlled experiments demonstrated major enhancements in the laboratory observing of particular high-risk drugs. However, The was not enough evidence to demonstrate the effect of HIT in improving laboratory observing of particular high-risk drugs for patients in ambulatory settings; thus, more studies are required. |